2 hours ago
Description
(AWP Alliance News) - JPMorgan Chase appointed Bruce N. Rogers as a venture partner at J.P. Morgan Life Sciences Private Capital. Rogers is president and CEO of a precision immunology portfolio company backed by the unit. He previously led Morphic Therapeutic, joining in 2016 as chief scientific officer, later serving as president, then moving to Eli Lilly in 2024 as senior vice president and CEO of Morphic following Lilly's USD 3.2 billion acquisition. Earlier, he was head of neuro-opportunities at Pfizer, with prior medicinal chemistry roles at Pfizer and Pharmacia.
https://www.prnewswire.com/news-releases/jp-morgan-life-sciences-privat…
Disclaimer: This news brief was created using generative artificial intelligence. JPMorgan Chase & Co. published the original content used to generate this news brief via PR Newswire on August 18, 2026, and is solely responsible for the information contained therein.
